Welcome Message
 
Our Company
 
Awards & Recognition
 
Corporate Governance
 
Management Council
Board of Directors
Reports of Insider Transactions
Committee Charters
Corporate Governance Guidelines
Additional Policies and Guidelines
Codes of Conduct
Articles of Incorporation (PDF)
Bylaws (PDF)
 
Corporate Compliance
 
Our Websites
 
Business Links

 

  » BMS.com Home » About Us » Corporate Governance » Carlo de Notaristefani, CIRM
SEARCH INDEX
 





Carlo de Notaristefani, CIRM

President, Technical Operations

John E. CelentanoCarlo de Notaristefani is responsible for the Bristol Myers Squibb Technical Operations organization, which meets the company’s complex supply chain challenges. Technical Operations plays a critical role in the company’s transformation into an increasingly agile and productive discoverer, developer and provider of innovative new medicines. In addition, his responsibilities encompass the Global Procurement organization.

“As a developing next-generation BioPharma leader,” says Carlo, “we are introducing new products and new technologies. We are moving into new markets. And we are experiencing more strictly regulated environments and higher volatility in those markets. More than ever before, Technical Operations plays a critical role in the success of the company.”

Carlo joined Bristol-Myers Squibb in early 2004 from Aventis Pharmaceuticals, where he was senior vice president of Global Finishing Solids. He spent nearly 20 years of his career at Aventis and its predecessors, Hoechst Marion Roussel and Marion Merrel Dow.

At Bristol-Myers Squibb, Carlo was appointed to the position of senior vice president of Global Manufacturing Operations in June 2004 and he assumed the position of president of Technical Operations in September 2004.

“Technical Operations plays a key role in fulfilling our mission to extend and enhance human life. And to do that, we must be absolutely compliant with all regulations and our own exacting standards, and we must flawlessly supply medicines to our customers. We need to be able to do that every day, every time a patient needs a medicine.”

Carlo is a certified professional engineer and holds a doctoral degree in engineering from the University of Naples, Italy. Through the course of his career, Carlo has moved across the Atlantic Ocean five times. He now resides happily in New Jersey. He and his wife have two grown sons.

June, 2008




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

SEARCH INDEX